277 related articles for article (PubMed ID: 31257949)
1. Timing use of novel anti-epileptic drugs: is earlier better?
de Biase S; Nilo A; Bernardini A; Gigli GL; Valente M; Merlino G
Expert Rev Neurother; 2019 Oct; 19(10):945-954. PubMed ID: 31257949
[No Abstract] [Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures.
de Biase S; Gigli GL; Nilo A; Romano G; Valente M
Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):93-102. PubMed ID: 30577702
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Patsalos PN; Berry DJ
Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
[TBL] [Abstract][Full Text] [Related]
4. Third generation antiepileptic drug monotherapies in adults with epilepsy.
Mula M
Expert Rev Neurother; 2016 Sep; 16(9):1087-92. PubMed ID: 27248204
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of epilepsy: newly approved and developmental agents.
Stephen LJ; Brodie MJ
CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
[TBL] [Abstract][Full Text] [Related]
6. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.
Stefanović S; Janković SM; Novaković M; Milosavljević M; Folić M
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):153-159. PubMed ID: 29268032
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide for the treatment of epilepsy.
de Biase S; Gigli GL; Valente M; Merlino G
Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):459-68. PubMed ID: 24479852
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for children and adolescents with epilepsy.
Verrotti A; Loiacono G; Coppola G; Spalice A; Mohn A; Chiarelli F
Expert Opin Pharmacother; 2011 Feb; 12(2):175-94. PubMed ID: 21208135
[TBL] [Abstract][Full Text] [Related]
11. Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review.
Palleria C; Cozza G; Khengar R; Libri V; De Sarro G
Curr Pharm Des; 2017; 23(37):5606-5624. PubMed ID: 28799510
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of epilepsy: recent advances and future prospects.
Johannessen Landmark C; Johannessen SI
Drugs; 2008; 68(14):1925-39. PubMed ID: 18778117
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for tonic-clonic seizures.
Rheims S; Ryvlin P
Expert Opin Pharmacother; 2014 Jul; 15(10):1417-26. PubMed ID: 24798217
[TBL] [Abstract][Full Text] [Related]
15. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
Neurology; 2018 Jul; 91(2):74-81. PubMed ID: 29898971
[TBL] [Abstract][Full Text] [Related]
16. [Epilepsy and breastfeeding: from myth to reality].
Cabo-Lopez I; Canneti B; Puy-Nunez A
Rev Neurol; 2019 Jul; 69(2):68-76. PubMed ID: 31287150
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and adverse effects of established and new antiepileptic drugs.
Mattson RH
Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
[TBL] [Abstract][Full Text] [Related]
18. New and forthcoming anti-epileptic drugs.
Prunetti P; Perucca E
Curr Opin Neurol; 2011 Apr; 24(2):159-64. PubMed ID: 21301338
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures.
de Biase S; Valente M; Gigli GL; Merlino G
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):997-1005. PubMed ID: 28750560
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.
Glauser T; Laurenza A; Yang H; Williams B; Ma T; Fain R
Epilepsy Res; 2016 Jan; 119():34-40. PubMed ID: 26656783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
